Longevity News

What Can Be Learned About Aging Clocks from Existing Clinical Trial Data for Longevity Interventions?

Source: Fight Aging! • Published: 31 Aug 2026, 18:12

What Can Be Learned About Aging Clocks from Existing Clinical Trial Data for Longevity Interventions?

Survey of how existing clinical trial methylation datasets reveal which epigenetic clocks respond to longevity interventions and why.

Key Takeaways
  • Curated TranslAGE database pooled 51 longitudinal interventional studies for consistent DNAm analysis
  • Clocks trained on mortality or pace-of-aging measures showed the strongest and most consistent responses
  • Pharmacological and lifestyle interventions drove the largest DNAm biomarker changes across studies
Read Original Source

Continue exploring

Related longevity signals

Fight Aging!Reviewing the State of Aging Clocks for the BrainA review surveys the development of brain-specific aging clocks, their multimodal methods, and applications for neurodegenerative risk prediction.Longevity TechnologyLongevity AI taps real-world data for disease risk preventionLongevity AI’s collaboration with clinicians tests whether updating familiar clinical risk tools using modern healthcare records could improve preventive care. Read this article to see how a pragmatic, data-driven refresh of everyday medical prediction models is being studied.Fight Aging!Senolytic Treatments Clear Harmful Senescent Microglia from the Aging BrainSenolytic-focused neuroscience reporting that previews mouse-based experiments probing whether targeted therapies can remodel age-linked inflammatory microglia in brain white matter.Fight Aging!Cytotoxic CD4+ T Cells in Aging, Both Protective and HarmfulA review examines cytotoxic CD4+ T cells that expand with age and how their protective and pathological roles influence age-related diseases.